Page 10 - Aduhelm News Today

(Reuters) — Patient groups are mounting a public pressure campaign aimed at persuading the U.S. government to loosen proposed restrictions on new Alzheimers treatments, spending millions of dollars on television

The chairman of the House Committee on Energy and Commerce is taking the FDA’s accelerated approval pathway to task. 

As members of Congress concerned about the many costs facing older Americans, we know that we must do more to lower the soaring cost of prescription drugs in this country.

The narrow 50-46 decision underscored the divisions on both sides of the aisle over agency policies on opioids and abortion medications and his ties to the drug industry.

Thankful for search and rescue volunteers

When Biogen cut the price of its Alzheimer's drug in half, it exposed the arbitrary nature of drug pricing.

Biogen expects “minimal” revenue this year from its Alzheimer’s treatment initially...

Biogen expects “minimal” sales this year from its Alzheimer’s treatment initially...

Biogen expects “minimal” sales this year from its Alzheimer’s treatment initially...

Biogen expects “minimal” sales this year from its Alzheimer’s treatment initially...